top of page
Management of CLL and the Role of Minimal Residual Disease (MRD)
Wed, May 12
|Zoom
Presented by Matthew Davids, MD, MMSc Associate Director of the CLL Center Dana-Farber Cancer Institute
Registration is Closed
Time & Location
May 12, 2021, 6:00 PM – 7:00 PM
Zoom
Guests
About The Event
Management of CLL and the Role of Minimal Residual Disease
Presented by Dr. Matthew Davids, MD, MMSc
Associate Director of the CLL Center
Dana-Farber Cancer Institute
Objectives:
Examine the data supporting MRD as a prognostic marker
bottom of page